Episode Details

Back to Episodes
291. 'Add-On' Drugs Raise Questions About Safety and Cost

291. 'Add-On' Drugs Raise Questions About Safety and Cost

Published 11 months, 3 weeks ago
Description

Add-ons are heavily promoted by drugmakers, and experts are calling for more scrutiny to ensure patient care remains the priority over industry profits.

Order Sharyl's bestseller “Slanted: How the News Media Taught Us to Love Censorship and Hate Journalism” at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Harper Collins⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Barnes & Noble⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Books a Million⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠IndieBound⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bookshop⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!

Subscribe to both of Sharyl's podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave a great review, and share with your friends! Support independent journalism by visiting the new ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sharyl Attkisson store⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Visit Sharyl Attkisson's Free Substack, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SharylAttkisson.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.FullMeasure.news⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for original reporting.

Do your own research. Make up your own mind. Think for yourself.


Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us